SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000898432-24-000110
Filing Date
2024-02-08
Accepted
2024-02-08 16:20:10
Documents
1
Group Members
BELLEVUE CAPITAL MANAGEMENT LLCKUK HYOUN HWANG

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g.htm SC 13G 128255
  Complete submission text file 0000898432-24-000110.txt   129961
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Subject) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93996 | Film No.: 24609365
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 (425) 635-7700
Bellevue Global Life Science Investors LLC (Filed by) CIK: 0001953768 (see all company filings)

IRS No.: 842636245 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G